HNX: PMC Statistics

Total Valuation

Pharmedic Pharmaceutical Medicinal JSC has a market cap or net worth of VND 1.11 trillion. The enterprise value is 905.76 billion.

Market Cap	1.11T
Enterprise Value	905.76B

Important Dates

The last earnings date was Thursday, January 16, 2025.

Earnings Date	Jan 16, 2025
Ex-Dividend Date	Feb 18, 2025

Share Statistics

Pharmedic Pharmaceutical Medicinal JSC has 9.33 million shares outstanding. The number of shares has increased by 36.99% in one year.

Current Share Class	n/a
Shares Outstanding	9.33M
Shares Change (YoY)	+36.99%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 18.92.

PE Ratio	18.92
Forward PE	n/a
PS Ratio	3.04
PB Ratio	5.05
P/TBV Ratio	3.85
P/FCF Ratio	28.22
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 23.09.

EV / Earnings	11.30
EV / Sales	1.82
EV / EBITDA	8.89
EV / EBIT	10.01
EV / FCF	23.09

Financial Position

The company has a current ratio of 3.89

Current Ratio	3.89
Quick Ratio	2.85
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 25.33% and return on invested capital (ROIC) is 17.87%.

Return on Equity (ROE)	25.33%
Return on Assets (ROA)	14.10%
Return on Capital (ROIC)	17.87%
Revenue Per Employee	932.93M
Profits Per Employee	150.06M
Employee Count	534
Asset Turnover	1.24
Inventory Turnover	4.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.05% in the last 52 weeks. The beta is 0.34, so Pharmedic Pharmaceutical Medicinal JSC's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+52.05%
50-Day Moving Average	115,800.00
200-Day Moving Average	94,385.50
Relative Strength Index (RSI)	56.23
Average Volume (20 Days)	4,382

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmedic Pharmaceutical Medicinal JSC had revenue of VND 498.18 billion and earned 80.13 billion in profits. Earnings per share was 6,268.00.

Revenue	498.18B
Gross Profit	187.21B
Operating Income	90.48B
Pretax Income	100.31B
Net Income	80.13B
EBITDA	101.92B
EBIT	90.48B
Earnings Per Share (EPS)	6,268.00

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	201.08B
Total Debt	n/a
Net Cash	201.08B
Net Cash Per Share	21,546.50
Equity (Book Value)	289.61B
Book Value Per Share	23,484.82
Working Capital	249.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 53.98 billion and capital expenditures -14.75 billion, giving a free cash flow of 39.23 billion.

Operating Cash Flow	53.98B
Capital Expenditures	-14.75B
Free Cash Flow	39.23B
FCF Per Share	4,203.23

Full Cash Flow Statement

Margins

Gross margin is 37.58%, with operating and profit margins of 18.16% and 16.09%.

Gross Margin	37.58%
Operating Margin	18.16%
Pretax Margin	20.14%
Profit Margin	16.09%
EBITDA Margin	20.46%
EBIT Margin	18.16%
FCF Margin	7.87%

Dividends & Yields

This stock pays an annual dividend of 19,100.00, which amounts to a dividend yield of 16.10%.

Dividend Per Share	19,100.00
Dividend Yield	16.10%
Dividend Growth (YoY)	2.56%
Years of Dividend Growth	n/a
Payout Ratio	137.95%
Buyback Yield	-36.99%
Shareholder Yield	-20.88%
Earnings Yield	7.24%
FCF Yield	3.54%

Dividend Details

Stock Splits

The last stock split was on January 8, 2013. It was a forward split with a ratio of 1.44.

Last Split Date	Jan 8, 2013
Split Type	Forward
Split Ratio	1.44

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a